114 related articles for article (PubMed ID: 32914663)
41. DJ-1 Expression in Cervical Carcinoma and its Effects on Cell Viability and Apoptosis.
Wang H; Gao W
Med Sci Monit; 2016 Aug; 22():2943-9. PubMed ID: 27544688
[TBL] [Abstract][Full Text] [Related]
42. The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cells.
Mazzacurati L; Lambert QT; Pradhan A; Griner LN; Huszar D; Reuther GW
Oncotarget; 2015 Nov; 6(37):40141-57. PubMed ID: 26472029
[TBL] [Abstract][Full Text] [Related]
43. PIM activity in tumours: A key node of therapy resistance.
Rebello RJ; Huglo AV; Furic L
Adv Biol Regul; 2018 Jan; 67():163-169. PubMed ID: 29111105
[TBL] [Abstract][Full Text] [Related]
44. Real-time quantitative RT-PCR assessment of PIM-1 and hK2 mRNA expression in benign prostate hyperplasia and prostate cancer.
He HC; Bi XC; Zheng ZW; Dai QS; Han ZD; Liang YX; Ye YK; Zeng GH; Zhu G; Zhong WD
Med Oncol; 2009; 26(3):303-8. PubMed ID: 19003546
[TBL] [Abstract][Full Text] [Related]
45. IL-6 stimulates STAT3 and Pim-1 kinase in pancreatic cancer cell lines.
Block KM; Hanke NT; Maine EA; Baker AF
Pancreas; 2012 Jul; 41(5):773-81. PubMed ID: 22273698
[TBL] [Abstract][Full Text] [Related]
46. Fra-1 is downregulated in cervical cancer tissues and promotes cervical cancer cell apoptosis by p53 signaling pathway in vitro.
Xiao S; Zhou Y; Yi W; Luo G; Jiang B; Tian Q; Li Y; Xue M
Int J Oncol; 2015 Apr; 46(4):1677-84. PubMed ID: 25651840
[TBL] [Abstract][Full Text] [Related]
47. Pim-2 activates API-5 to inhibit the apoptosis of hepatocellular carcinoma cells through NF-kappaB pathway.
Ren K; Zhang W; Shi Y; Gong J
Pathol Oncol Res; 2010 Jun; 16(2):229-37. PubMed ID: 19821157
[TBL] [Abstract][Full Text] [Related]
48. Up-regulation of a serine-threonine kinase proto-oncogene Pim-1 in oral squamous cell carcinoma.
Chiang WF; Yen CY; Lin CN; Liaw GA; Chiu CT; Hsia YJ; Liu SY
Int J Oral Maxillofac Surg; 2006 Aug; 35(8):740-5. PubMed ID: 16546353
[TBL] [Abstract][Full Text] [Related]
49. Expression of pim-1 in tumors, tumor stroma and tumor-adjacent mucosa co-determines the prognosis of colon cancer patients.
Peng YH; Li JJ; Xie FW; Chen JF; Yu YH; Ouyang XN; Liang HJ
PLoS One; 2013; 8(10):e76693. PubMed ID: 24116137
[TBL] [Abstract][Full Text] [Related]
50. Expression of PIM kinases in Reed-Sternberg cells fosters immune privilege and tumor cell survival in Hodgkin lymphoma.
Szydłowski M; Prochorec-Sobieszek M; Szumera-Ciećkiewicz A; Derezińska E; Hoser G; Wasilewska D; Szymańska-Giemza O; Jabłońska E; Białopiotrowicz E; Sewastianik T; Polak A; Czardybon W; Gałęzowski M; Windak R; Zaucha JM; Warzocha K; Brzózka K; Juszczyński P
Blood; 2017 Sep; 130(12):1418-1429. PubMed ID: 28698206
[TBL] [Abstract][Full Text] [Related]
51. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
Wei L; Qin XP; Zhao XX; Wang W
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
[No Abstract] [Full Text] [Related]
52. Up-regulation of long non-coding RNA MFI2 functions as an oncogenic role in cervical cancer progression.
Qu B; Zhao AH; Nie XZ; Sui R; Du MM; Jiang L; Wang HL
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4680-4687. PubMed ID: 31210294
[TBL] [Abstract][Full Text] [Related]
53. USP18 promotes cell proliferation and suppressed apoptosis in cervical cancer cells via activating AKT signaling pathway.
Diao W; Guo Q; Zhu C; Song Y; Feng H; Cao Y; Du M; Chen H
BMC Cancer; 2020 Aug; 20(1):741. PubMed ID: 32770981
[TBL] [Abstract][Full Text] [Related]
54. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
Cao S; Liu W; Li F; Zhao W; Qin C
Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
[TBL] [Abstract][Full Text] [Related]
55. LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway.
Hsu W; Liu L; Chen X; Zhang Y; Zhu W
Biol Res; 2019 Jun; 52(1):33. PubMed ID: 31255182
[TBL] [Abstract][Full Text] [Related]
56. Identification of stemonamide synthetic intermediates as a novel potent anticancer drug with an apoptosis-inducing ability.
Li YY; Wang YY; Taniguchi T; Kawakami T; Baba T; Ishibashi H; Mukaida N
Int J Cancer; 2010 Jul; 127(2):474-84. PubMed ID: 19921695
[TBL] [Abstract][Full Text] [Related]
57. Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts.
Santio NM; Eerola SK; Paatero I; Yli-Kauhaluoma J; Anizon F; Moreau P; Tuomela J; Härkönen P; Koskinen PJ
PLoS One; 2015; 10(6):e0130340. PubMed ID: 26075720
[TBL] [Abstract][Full Text] [Related]
58. Effects of MACC1 siRNA on biological behaviors of HeLa.
Chai H; Yang Y
Arch Gynecol Obstet; 2014 Jun; 289(6):1271-80. PubMed ID: 24346124
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.
Woodworth CD; Diefendorf LP; Jette DF; Mohammed A; Moses MA; Searleman SA; Stevens DA; Wilton KM; Mondal S
Virology; 2011 Dec; 421(1):19-27. PubMed ID: 21982220
[TBL] [Abstract][Full Text] [Related]
60. Analysis of gene mutation associated with tyrosine kinase inhibitor sensitivity of epidermal growth factor receptor in cervical cancer patients.
Wei H; Wang XW; Chen KM; Ling SR; Yi CJ
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6280-6287. PubMed ID: 30338793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]